Skip to main content
RXRX logo

RXRX · Recursion Pharmaceuticals, Inc. · Exempt Offerings

Track RXRX — free
$3.25 -0.20 (-5.67%)
Market Cap
$1.94B
Shares
535.34M

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

Filed Type Offering Sold
2020-11-12 Amendment $245,896,677 $245,896,677
2020-09-15 New $235,506,731 $235,506,731
Showing 1–2 of 2 filings
Key facts CIK 1601830 CUSIP 75629V104 13F (30d) 194 filings 194 filers Visit website Investor relations